{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T16:07:48Z","timestamp":1776960468513,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.dld.2008.04.002","type":"journal-article","created":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T20:19:23Z","timestamp":1215461963000},"page":"357-363","source":"Crossref","is-referenced-by-count":56,"title":["Persistent elevation of serum CA 19-9 with no evidence of malignant disease"],"prefix":"10.1016","volume":"41","author":[{"given":"M.","family":"Ventrucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Pozzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cipolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Uomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 4","key":"10.1016\/j.dld.2008.04.002_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1008386130283","article-title":"Role of tumour markers, cytogenetics","volume":"10","author":"Lamerz","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.dld.2008.04.002_bib2","first-page":"332","article-title":"Serum tumor markers for pancreatic cancer: the dawn of new era?","volume":"7","author":"Okusaka","year":"2006","journal-title":"J Pancreas"},{"key":"10.1016\/j.dld.2008.04.002_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00006676-199201000-00011","article-title":"Diagnosis of pancreatic carcinoma. Imaging techniques and tumor markers","volume":"7","author":"Niederau","year":"1992","journal-title":"Pancreas"},{"key":"10.1016\/j.dld.2008.04.002_bib4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3748\/wjg.v10.i3.427","article-title":"Utility of serum CA 19-9 in diagnosis of cholangiocarcinoma in comparison with CEA","volume":"10","author":"Qin","year":"2004","journal-title":"Word J Gastroenterol"},{"key":"10.1016\/j.dld.2008.04.002_bib5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jso.20604","article-title":"CEA, CA 19-9, and CA125 in the differential diagnosis of benign and malignant pancreatic diseases with or without jaundice","volume":"95","author":"Duraker","year":"2007","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.dld.2008.04.002_bib6","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/archsurg.141.10.968","article-title":"Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions","volume":"141","author":"Cwik","year":"2006","journal-title":"Arch Surg"},{"key":"10.1016\/j.dld.2008.04.002_bib7","first-page":"5195","article-title":"Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer","volume":"20","author":"Reiter","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1016\/j.dld.2008.04.002_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1385\/IJGC:31:1-3:155","article-title":"Differences in plasma gastrin, CEA, and CA 19-9 concentration in patients with proximal and distal colorectal cancer","volume":"31","author":"Bombski","year":"2002","journal-title":"Int J Gastrointest Cancer"},{"key":"10.1016\/j.dld.2008.04.002_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00000421-199708000-00005","article-title":"CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma","volume":"20","author":"Pectasides","year":"1997","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.dld.2008.04.002_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.biopha.2003.11.003","article-title":"Serum tumour markers in the management of ovarian, endometrial and cervical cancer","volume":"58","author":"Gadducci","year":"2004","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.dld.2008.04.002_bib11","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-2362.1992.tb01449.x","article-title":"Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases","volume":"22","author":"Basso","year":"1992","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.dld.2008.04.002_bib12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/172460080001500304","article-title":"Cholestasis is the main determinant of abnormal CA 19-9 levels in patients with liver cirrhosis","volume":"15","author":"Giannini","year":"2000","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.dld.2008.04.002_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/000456329803500113","article-title":"The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEA","volume":"35","author":"Maestranzi","year":"1998","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.dld.2008.04.002_bib14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/003655299750026461","article-title":"Carbohydrate 19-9 antigen as a marker of non-malignant hepatocytic ductular transformation in patients with acute liver failure. A comparison with alpha-fetoprotein and carcinoembryonic antigen","volume":"34","author":"Halme","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2008.04.002_bib15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s10620-006-3135-x","article-title":"The combined elevation of tumor markers CA 19-9 and CA 125 in liver disease patients is highly specific for severe liver fibrosis","volume":"51","author":"Schoniger-Hekele","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.04.002_bib16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/gut.41.4.e577","article-title":"An exceptional high concentration of serum CA 19.9 in a patient with alcoholic liver disease","volume":"41","author":"de Goede","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.04.002_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10238-003-0014-z","article-title":"Serum CA 19-9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests","volume":"3","author":"Augarten","year":"2003","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.dld.2008.04.002_bib18","first-page":"641","article-title":"Unusually high CA19-9 in chronic pancreatitis","volume":"19","author":"Pines","year":"1995","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.dld.2008.04.002_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00006676-200011000-00001","article-title":"Acute pancreatitis secondary to pancreatic carcinoma. Study Group participants","volume":"21","author":"Mujica","year":"2000","journal-title":"Pancreas"},{"key":"10.1016\/j.dld.2008.04.002_bib20","first-page":"17","article-title":"Elevated serum CA19-9 levels in poorly controlled diabetic patients. Relationship with Lewis blood group","volume":"18","author":"Petit","year":"1994","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.dld.2008.04.002_bib21","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1164\/ajrccm\/148.3.744","article-title":"Elevation of tumor-associated carbohydrate antigens in patients with diffuse panbronchiolitis","volume":"148","author":"Mukae","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.dld.2008.04.002_bib22","first-page":"77","article-title":"Clinical characterization of CA 19-9 in patients with interstitial pneumonia showing pathological nonspecific interstitial pneumonia pattern","volume":"43","author":"Totani","year":"2005","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"10.1016\/j.dld.2008.04.002_bib23","first-page":"599","article-title":"Increase of CA 19.9 in dysimmune inflammatory rheumatism. Apropos of 6 cases","volume":"61","author":"Cantagrel","year":"1994","journal-title":"Rev Rhum Ed Fr"},{"key":"10.1016\/j.dld.2008.04.002_bib24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0015-0282(02)03328-9","article-title":"Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis","volume":"78","author":"Harada","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.dld.2008.04.002_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000282887","article-title":"Immunohistochemical study of CA 19-9 and SPan-1 in cases of hydronephrosis","volume":"57","author":"Inayama","year":"1996","journal-title":"Urol Int"},{"key":"10.1016\/j.dld.2008.04.002_bib26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1590-8658(01)80114-6","article-title":"Ruptured epidermoid cyst and haematoma of spleen: a diagnostic clue of high levels of serum carcinoembryonic antigen, carbohydrate antigen 19-9 and Sialyl Lewis x","volume":"33","author":"Matsubayashi","year":"2001","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.04.002_bib27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/dote\/11.2.130","article-title":"Bronchogenic cyst of the esophagus with high tumor marker levels\u2014a case report and review of the literature","volume":"11","author":"Ott","year":"1998","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.dld.2008.04.002_bib28","first-page":"380","article-title":"Very high elevation of CA19-9 level in a patient with steatosis","volume":"68","author":"Vandemergel","year":"2005","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.dld.2008.04.002_bib29","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s005950200037","article-title":"Diverticulitis causing a high serum level of carbohydrate antigen 19-9: report of a case","volume":"32","author":"Nakamura","year":"2002","journal-title":"Surg Today"},{"key":"10.1016\/j.dld.2008.04.002_bib30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4065\/77.4.398","article-title":"Hypothyroidism-related CA 19-9 elevation","volume":"77","author":"Tekin","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.dld.2008.04.002_bib31","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/gut.52.6.913","article-title":"A new cause for CA19-9 elevation: heavy tea consumption","volume":"52","author":"Howaizi","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.04.002_bib32","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1515\/CCLM.2001.205","article-title":"Comparison of different immunoassays for CA19-9","volume":"39","author":"Stern","year":"2001","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.dld.2008.04.002_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1515\/CCLM.1998.033","article-title":"Serum CA 242: the search for a valid marker of pancreatic cancer","volume":"36","author":"Ventrucci","year":"1998","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.dld.2008.04.002_bib34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1515\/CCLM.2007.003","article-title":"Interchangeability of measurements of CA 19-9 in serum with four frequently used assays: an update","volume":"45","author":"Passerini","year":"2007","journal-title":"Clin Chem Lab Med"},{"issue":"Suppl. II","key":"10.1016\/j.dld.2008.04.002_bib35","first-page":"ii31","article-title":"Chronic pancreatitis and cystic fibrosis","volume":"52","author":"Witt","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.04.002_bib36","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1023\/B:DDAS.0000037803.32013.aa","article-title":"Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer","volume":"49","author":"Ventrucci","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.04.002_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00007611-199701000-00023","article-title":"Elevated tumor-associated antigen CA 19-9 in a patient with an enlarged pancreas: does it always imply malignancy?","volume":"90","author":"Tolliver","year":"1997","journal-title":"South Med J"},{"key":"10.1016\/j.dld.2008.04.002_bib38","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/j.1572-0241.1999.01234.x","article-title":"A new strategy for the application of CA 19-9 in the differentiation of pancreaticobiliary cancer: analysis using receiver operating characteristic curve","volume":"94","author":"Kim","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.04.002_bib39","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2169\/internalmedicine.31.516","article-title":"A case of common bile duct stone with cholangitis presenting an extraordinary high serum CA 19-9 value","volume":"31","author":"Murohisa","year":"1992","journal-title":"Intern Med"},{"key":"10.1016\/j.dld.2008.04.002_bib40","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1053\/ejso.1999.0925","article-title":"Elevated tumour marker CA19.9: clinical interpretation and influence of obstructive jaundice","volume":"26","author":"Mann","year":"2000","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.dld.2008.04.002_bib41","first-page":"1370","article-title":"Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA 19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice","volume":"85","author":"Ohshio","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.04.002_bib42","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/02841860152703535","article-title":"Measurement of serum CA 19-9 in biliary diseases requires great caution","volume":"40","author":"Dorizzi","year":"2001","journal-title":"Acta Oncologica"},{"key":"10.1016\/j.dld.2008.04.002_bib43","first-page":"2931","article-title":"Biliary mucin secreted by cultured human gallbladder epithelial cells carries the epitope of CA 19-9","volume":"17","author":"von Ritter","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/j.dld.2008.04.002_bib44","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s10620-006-9532-3","article-title":"CA 19-9 to rule out pancreatic or biliary cancer among patients with cholestasis: an unsuitable test?","volume":"52","author":"Madonia","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.04.002_bib45","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.coph.2005.10.005","article-title":"Systemic amyloidosis","volume":"6","author":"Lachmann","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.dld.2008.04.002_bib46","doi-asserted-by":"crossref","unstructured":"ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;24:5313\u201327.","DOI":"10.1200\/JCO.2006.08.2644"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865808001783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865808001783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T14:13:58Z","timestamp":1557670438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865808001783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S1590865808001783"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2008.04.002","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}